Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics
(41O.F) Q1 2026
Earnings
41O.F
Feb 17
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.49
-0.34
-0.2
-0.05
Details
Expected EPS
-0.19122081454
Actual EPS
-0.18559640000000002
Surprise EPS
0.01
Surprise Percent
+2.94%
Description
Outlook Therapeutics (41O.F) has reported earnings of -0.18559640000000002 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login